The intent of this RFP is to encourage proposals for the implementation of strategies that will measurably improve the quality of care of persons with mBC. Projects should use optimal measures to improve care for persons with mBC, where treatment goals focus on improving quality and length of life as there is, to date, no known cure. We welcome a diversity of projects that will improve the outcomes of persons with metastatic breast cancer  including pilot projects that could lead to larger efforts that could potentially impact clinical care. Well thought out and tested modifications allow for more efficient and effective patient care. Providing appropriate resources and education to people with mBC, their caregivers, and family members is crucial to help ensure they are informed and can participate in the shared clinical decision-making process. While the digital delivery of care can provide persons with mBC with flexibility and health care providers with further reach, submissions that underscore the importance of person-to-person care are also appreciated.

The specific objectives of this funding opportunity are to:

• generate new and ongoing population estimates of the use of controlled substances in Canada;
• generate new and ongoing knowledge of trends related to controlled substances from wastewater analyses and from other relevant sources in jurisdictions across Canada; and
• ensure the sharing of the generated population estimates and real-time trends of the use of controlled substances with local, provincial, territorial, national and international knowledge users, through a publicly accessible website.

Between the 1950s and mid-1990s, LGBT members of the Canadian Armed Forces (CAF), the Royal Canadian Mounted Police (RCMP), and the federal public service were systematically discriminated against, harassed, and often fired as a matter of policy and sanctioned practice. In what came to be known as the “LGBT Purge,” people were followed, interrogated, abused, and traumatized. The LGBT Purge was implemented at the highest levels of the Government of Canada and was carried out with callous disregard for the dignity, privacy, and humanity of its victims (LGBT Purge Fund website, 2020).

VAC invites applications for research that explores the intersectionality of LGBT Purge survivors’ experiences and characteristics, conduct a qualitative research study of LGBT Purge survivors’ experiences when seeking support from and accessing VAC programs and services, and make recommendations for VAC programs and services to account for the identified LGBT Purge Survivor characteristics’ specific considerations when applying for VAC programs and services.

Connection Grants are expected to respond to the objectives of the Research Partnerships program.

These grants support events and outreach activities geared toward short-term, targeted knowledge mobilization initiatives. These events and activities represent opportunities to exchange knowledge and engage with participants on research issues they  value. Events and outreach activities funded by a Connection Grant can often serve as a first step toward more comprehensive and longer-term projects.

Connection Grants support workshops, colloquiums, conferences, forums, summer institutes or other events or outreach activities that facilitate:

• disciplinary and/or interdisciplinary exchanges in the social sciences and humanities;
• scholarly exchanges between those working in the social sciences and humanities and those working in other research fields;
• intersectoral exchanges between academic researchers in the social sciences and humanities and researchers and practitioners from the public, private and/or not-for-profit sectors; and/or
• international research collaboration and scholarly exchanges with researchers, students and non-academic partners from other countries.

The project grant program supports small-budget proposals for research projects in the history of medicine and allied disciplines such as science and technology studies, sociology, anthropology, and classics. Projects must strive to advance the history of health, healthcare and disease, or the education of health professionals.

Click here to see projects that AMS Healthcare has funded from previous competitions.

AMS Healthcare will support up to seven (7) AMS History of Medicine Project Grants per year of up to $20,000 per grant.

Working together, the Government of Canada and the Government of Germany aim to foster and support collaborative industrial research and development (R&D) projects with high potential for commercialization. This call for proposals is open to companies from Canada and Germany who wish to perform joint R&D leading to technology commercialization focused on developing innovative products, processes, or technology-based services in all technological and application areas which have strong market potential.

The National Research Council of Canada (NRC) and the German Federal Ministry for Economic Affairs and Climate Action (BMWK) will provide access to public funding for joint projects through the BMWK's ZIM program (Central Innovation Program for SMEs) in Germany, and through the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) in Canada.

For more information, please contact Jill Sherman at intl.research@lakeheadu.ca.

Neurodegenerative diseases are debilitating and largely untreatable conditions that are strongly linked with age. Worldwide, there are estimated to be 50 million people with Alzheimer’s disease and related disorders, the most common group of neurodegenerative diseases. This figure is expected to double every 20 years as the population ages. With very few causal treatments being available today, neurodegenerative diseases have high personal, societal and economic impact.

In this context, the EU Joint Programme - Neurodegenerative Disease Research (JPND) has been established to better coordinate research efforts across countries and disciplines to find causes, develop cures and identify better ways to care for people with neurodegenerative diseases.

It is known that the onset of neurodegenerative diseases occurs years before the appearance of the first clinical symptoms. However, our current understanding on the biological, psychological and social mechanisms that determine early disease progression as well as our ability to precisely monitor the course of the disease at pre-symptomatic stages is very limited. Delayed detection of disease progression may be the reason for the multiple failures observed in clinical trials during the past years. In this context, improving our understanding of the crucial biological mechanisms and psychosocial factors determining risk and resilience for neurodegenerative diseases is needed along with an enhanced measurability of disease progression through the establishment of advanced biological and psychosocial markers. Respective advancements may allow a more accurate identification of pre-symptomatic disease stages and a reliable monitoring of disease progression, thereby enabling a better prediction of disease trajectories and paving the way for new therapeutic and preventive approaches.

For this reason, CIHR is joining JPND on their launch of this joint transnational call with the aim of improving the understanding of disease mechanisms and advancing measurability of disease progression at early and pre-symptomatic stages of neurodegenerative diseases.

For more information, please consult the JPND Call for Proposals.

For more information, please contact Jill Sherman at intl.research@lakeheadu.ca.